Lind Global Fund III LP 13D/13G Filings for FibroBiologics, Inc. Common Stock (FBLG)

Lind Global Fund III LP 13D and 13G filings for FibroBiologics, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-09
4:30 pm
Purchase
2026-04-0213GFIBROBIOLOGICS INC
FBLG
Lind Global Fund III LP230,234
4.990%
230,234increase
(New Position)
Filing